85 related articles for article (PubMed ID: 24297537)
1. Multiplex meta-analysis of medulloblastoma expression studies with external controls.
Morgan AA; Achrol AS; Li MD; Khatri PJ; Cheshier SH
Pac Symp Biocomput; 2014; ():99-109. PubMed ID: 24297537
[TBL] [Abstract][Full Text] [Related]
2. Identification of genes that are regulated transcriptionally by Myc in childhood tumors.
Raetz EA; Kim MK; Moos P; Carlson M; Bruggers C; Hooper DK; Foot L; Liu T; Seeger R; Carroll WL
Cancer; 2003 Aug; 98(4):841-53. PubMed ID: 12910530
[TBL] [Abstract][Full Text] [Related]
3. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.
Tong CY; Hui AB; Yin XL; Pang JC; Zhu XL; Poon WS; Ng HK
J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):187-93. PubMed ID: 14758948
[TBL] [Abstract][Full Text] [Related]
4. Identification of cell surface targets through meta-analysis of microarray data.
Haeberle H; Dudley JT; Liu JT; Butte AJ; Contag CH
Neoplasia; 2012 Jul; 14(7):666-9. PubMed ID: 22904683
[TBL] [Abstract][Full Text] [Related]
5. Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment.
Liang Y; Diehn M; Bollen AW; Israel MA; Gupta N
J Neurooncol; 2008 Jan; 86(2):133-41. PubMed ID: 17653508
[TBL] [Abstract][Full Text] [Related]
6. Spectral biclustering of microarray data: coclustering genes and conditions.
Kluger Y; Basri R; Chang JT; Gerstein M
Genome Res; 2003 Apr; 13(4):703-16. PubMed ID: 12671006
[TBL] [Abstract][Full Text] [Related]
7. Overlay analysis of the oligonucleotide array gene expression profiles and copy number abnormalities as determined by array comparative genomic hybridization in medulloblastomas.
Lo KC; Rossi MR; Burkhardt T; Pomeroy SL; Cowell JK
Genes Chromosomes Cancer; 2007 Jan; 46(1):53-66. PubMed ID: 17044047
[TBL] [Abstract][Full Text] [Related]
8. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
Thompson MC; Fuller C; Hogg TL; Dalton J; Finkelstein D; Lau CC; Chintagumpala M; Adesina A; Ashley DM; Kellie SJ; Taylor MD; Curran T; Gajjar A; Gilbertson RJ
J Clin Oncol; 2006 Apr; 24(12):1924-31. PubMed ID: 16567768
[TBL] [Abstract][Full Text] [Related]
9. A molecular fingerprint for medulloblastoma.
Lee Y; Miller HL; Jensen P; Hernan R; Connelly M; Wetmore C; Zindy F; Roussel MF; Curran T; Gilbertson RJ; McKinnon PJ
Cancer Res; 2003 Sep; 63(17):5428-37. PubMed ID: 14500378
[TBL] [Abstract][Full Text] [Related]
10. Emerging treatments and gene expression profiling in high-risk medulloblastoma.
Sardi I; Cavalieri D; Massimino M
Paediatr Drugs; 2007; 9(2):81-96. PubMed ID: 17407364
[TBL] [Abstract][Full Text] [Related]
11. Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma.
Vibhakar R; Foltz G; Yoon JG; Field L; Lee H; Ryu GY; Pierson J; Davidson B; Madan A
Neuro Oncol; 2007 Apr; 9(2):135-44. PubMed ID: 17329407
[TBL] [Abstract][Full Text] [Related]
12. Progress in sequencing human cancer genomes: advancements in childhood medulloblastoma.
Komotar RJ; Starke RM; Connolly ES; Sisti MB
Neurosurgery; 2011 Oct; 69(4):N13-5. PubMed ID: 21900800
[No Abstract] [Full Text] [Related]
13. Cross-platform comparison and visualisation of gene expression data using co-inertia analysis.
Culhane AC; Perrière G; Higgins DG
BMC Bioinformatics; 2003 Nov; 4():59. PubMed ID: 14633289
[TBL] [Abstract][Full Text] [Related]
14. A transcriptome-based classifier to determine molecular subtypes in medulloblastoma.
Rathi KS; Arif S; Koptyra M; Naqvi AS; Taylor DM; Storm PB; Resnick AC; Rokita JL; Raman P
PLoS Comput Biol; 2020 Oct; 16(10):e1008263. PubMed ID: 33119584
[TBL] [Abstract][Full Text] [Related]
15. Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma.
Zhou L; Picard D; Ra YS; Li M; Northcott PA; Hu Y; Stearns D; Hawkins C; Taylor MD; Rutka J; Der SD; Huang A
Cancer Res; 2010 Oct; 70(20):8199-210. PubMed ID: 20876797
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive genomic analysis of desmoplastic medulloblastomas: identification of novel amplified genes and separate evaluation of the different histological components.
Ehrbrecht A; Müller U; Wolter M; Hoischen A; Koch A; Radlwimmer B; Actor B; Mincheva A; Pietsch T; Lichter P; Reifenberger G; Weber RG
J Pathol; 2006 Mar; 208(4):554-63. PubMed ID: 16400626
[TBL] [Abstract][Full Text] [Related]
17. Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma.
Pfister S; Schlaeger C; Mendrzyk F; Wittmann A; Benner A; Kulozik A; Scheurlen W; Radlwimmer B; Lichter P
Nucleic Acids Res; 2007; 35(7):e51. PubMed ID: 17344319
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma.
Lindsey JC; Lusher ME; Anderton JA; Gilbertson RJ; Ellison DW; Clifford SC
Br J Cancer; 2007 Jul; 97(2):267-74. PubMed ID: 17579622
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive high-resolution genomic profiling and cytogenetics of two pediatric and one adult medulloblastoma.
Holland H; Xu LX; Ahnert P; Kirsten H; Koschny R; Bauer M; Schober R; Meixensberger J; Krupp W
Pathol Res Pract; 2013 Sep; 209(9):541-7. PubMed ID: 23896263
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
